|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$0.42 |
$0.46 |
$0.40 |
$0.45 |
334.80K | 04/22/2024 |
$0.44 |
$0.45 |
$0.43 |
$0.44 |
84.90K | 04/23/2024 |
$0.44 |
$0.45 |
$0.40 |
$0.43 |
473.10K | 04/24/2024 |
$0.40 |
$0.44 |
$0.40 |
$0.42 |
193.10K | 04/25/2024 |
$0.42 |
$0.42 |
$0.40 |
$0.42 |
271.10K |
|
RedHill Biopharma is a biopharmaceutical company that focuses on commercialization and development of proprietary drugs for gastrointestinal (GI) diseases. The ongoing development programs of Co.'s therapeutic candidates, most in late-stage clinical development, include: RHB-204, which is for the treatment of mycobacterium avium complex disease; RHB-104, which is an investigational drug intended to treat Crohn's disease; RHB-102 (Bekinda®), which is an investigational once-daily bi-modal extended-release oral formulation of ondansetron; and RHB-106, which is an investigational tablet intended for the preparation and cleansing of the GI tract prior to the performance of abdominal procedures. | |
|
Redhill Biopharma Ltd Ramat Gan (RDHL) has the following price history information. Looking back at RDHL historical stock prices for the last five trading days, on April 19, 2024, RDHL opened at $0.42, traded as high as $0.46 and as low as $0.40, and closed at $0.45. Trading volume was a total of 334.80K shares. On April 22, 2024, RDHL opened at $0.44, traded as high as $0.45 and as low as $0.43, and closed at $0.44. Trading volume was a total of 84.90K shares. On April 23, 2024, RDHL opened at $0.44, traded as high as $0.45 and as low as $0.40, and closed at $0.43. Trading volume was a total of 473.10K shares. On April 24, 2024, RDHL opened at $0.40, traded as high as $0.44 and as low as $0.40, and closed at $0.42. Trading volume was a total of 193.10K shares. On April 25, 2024, RDHL opened at $0.42, traded as high as $0.42 and as low as $0.40, and closed at $0.42. Trading volume was a total of 271.10K shares.
RDHL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Redhill Biopharma Ltd Ramat Gan shares, starting with a $10,000 purchase of RDHL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$567.20 |
|
End price/share: |
$0.42 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.93% |
|
Average Annual Total Return: |
-51.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7.34 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $0.45 | 04/22/2024 | $0.44 | 04/23/2024 | $0.43 | 04/24/2024 | $0.42 | 04/25/2024 | $0.42 |
|
|